Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001405253-26-000013

Farrow Jeffrey S sold 14,396 shares at $60.95 ($877,436)

  • Farrow Jeffrey S acquired 27,881 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Farrow Jeffrey S

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-15 Exercise or conversion : show line 1 in the form +27,881 71,197 D
2026-06-16 Sale : show line 2 in the form −14,396 $60.95 $877,436 56,801 D
Open-market sales · 14,396 sh · avg $60.95 · $877,436

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-15 Exercise or conversion : show line 3 in the form Restricted Stock Units −27,881 27,882 D
Loading xslF345X06/wk-form4_1781727451.xml…